ljc 10627 has been researched along with Infections, Pseudomonas in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoh, T; Hirota, K; Hori, K; Igarashi, J; Irie, Y; Kariyama, R; Kumon, H; Miyake, Y; Murakami, K; Suga, H; Viducic, D | 1 |
| Chen, Y; Gao, J; Hang, Y; Jin, J; Liu, L; Miao, L; Sun, S; Xie, C; Xue, L; Zhang, X; Zhu, J | 1 |
| Harada, Y; Hasegawa, H; Imamura, Y; Izumikawa, K; Kakeya, H; Kaku, N; Kohno, S; Migiyama, Y; Miyazaki, T; Morinaga, Y; Nagaoka, K; Nakamura, S; Yamada, K; Yanagihara, K; Yasuoka, A | 1 |
| Hayashi, T; Katoh, T; Kawai, Y; Kurihara, T; Miyashita, N; Okimoto, N | 1 |
| Derendorf, H; Ikawa, K; Ikeda, K; Morikawa, N; Murakami, Y; Nakashima, A; Ohge, H; Sueda, T | 1 |
| Araki, N; Harada, Y; Hasegawa, H; Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Morinaga, Y; Yamada, K; Yamamoto, Y; Yanagihara, K | 1 |
| Aizawa, K; Sakakibara, S; Shimizu, A; Takata, T; Totsuka, K; Watabe, H | 1 |
| Miyazaki, S | 1 |
| Hikida, M; Kawabata, T; Maebashi, K; Niida, M; Sakakibara, S; Takata, T | 1 |
| Kobayashi, Y; Sumitani, Y | 1 |
| Hikida, M; Kawashima, K; Mitsuhashi, S; Nishiki, K; Yamazaki, Y; Yoshida, M | 1 |
| Horii, T; Ichiyama, S; Kobayashi, M; Ohta, M | 1 |
| Andrews, JM; Catchpole, CR; Thornber, D; Wise, R | 1 |
13 other study(ies) available for ljc 10627 and Infections, Pseudomonas
| Article | Year |
|---|---|
A Pseudomonas aeruginosa Quorum-Sensing autoinducer analog enhances the activity of antibiotics against resistant strains.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Synergism; Homoserine; Humans; Lactones; Mice; Mice, Inbred ICR; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Thienamycins | 2017 |
Evaluating biapenem dosage regimens in intensive care unit patients with Pseudomonas aeruginosa infections: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; China; Female; Humans; Infusions, Intravenous; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Prospective Studies; Pseudomonas Infections; Thienamycins; Time Factors; Young Adult | 2018 |
In vivo efficacy of biapenem with ME1071, a novel metallo-β-lactamase (MBL) inhibitor, in a murine model mimicking ventilator-associated pneumonia caused by MBL-producing Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Bronchoalveolar Lavage Fluid; Cytokines; Drug Therapy, Combination; Inflammation; Lung; Maleates; Mice; Microbial Sensitivity Tests; Neutrophils; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Survival; Thienamycins; Treatment Outcome | 2013 |
Clinical effect of biapenem on nursing and healthcare-associated pneumonia (NHCAP).
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Cross Infection; Drug Eruptions; Female; Fever; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Severity of Illness Index; Staphylococcal Infections; Thienamycins | 2015 |
Clinical pharmacokinetics of meropenem and biapenem in bile and dosing considerations for biliary tract infections based on site-specific pharmacodynamic target attainment.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bile; Biliary Tract; Dose-Response Relationship, Drug; Drug Administration Schedule; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2011 |
In vivo efficacy and pharmacokinetics of biapenem in a murine model of ventilator-associated pneumonia with Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Colony Count, Microbial; Disease Models, Animal; Histocytochemistry; Lung; Male; Meropenem; Mice; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Specific Pathogen-Free Organisms; Statistics, Nonparametric; Thienamycins | 2012 |
Optimization of dose and dose regimen of biapenem based on pharmacokinetic and pharmacodynamic analysis.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Drug Administration Schedule; Humans; Imipenem; Male; Meropenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Thigh | 2004 |
Optimization of dose and dose regimen of biapenem based on pharmacokinetic and pharmacodynamic analysis.
Topics: Animals; Anti-Bacterial Agents; Drug Administration Schedule; Humans; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Thigh; Time Factors | 2004 |
[Combined effects of arbekacin with biapenem against in vitro and in vivo model of a mixture of MRSA and Pseudomonas aeruginosa].
Topics: Aminoglycosides; Animals; Anti-Infective Agents; Dibekacin; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Thienamycins | 2004 |
[Analysis on the effective dosage regimens for meropenem, biapenem and doripenem against P. aeruginosa infection based on pharmacokinetics and pharmacodynamics theory].
Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Meropenem; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2007 |
Postantibiotic effect of carbapenems against Pseudomonas aeruginosa.
Topics: Animals; Ceftazidime; Cephalosporins; Female; Imipenem; Meropenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1995 |
Relationship between morphological changes and endotoxin release induced by carbapenems in Pseudomonas aeruginosa.
Topics: Carbapenems; Endotoxins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1999 |
In vitro activity of L-627, a new carbapenem.
Topics: Bacteria; Bacterial Outer Membrane Proteins; Microbial Sensitivity Tests; Protein Binding; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1992 |